Infinity QS International Inc. has published a new electronic book, "Transforming the Vaccine Manufacturing Chain: How Pharmaceutical Companies Can Ensure Quality and Accelerate Time to Market."
The furious pace of M&A activity in life sciences indicates there is serious money to be made there. But successful companies must quickly adapt their supply chains to the challenges that shifting customer needs and industry regulations bring. Five crucial ideas that winners must understand are outlined below.
Over the years, we've seen the terms cold chain distribution, temperature-controlled distribution, temperature-sensitive distribution and logistics, among others in the pharmaceutical industry. Is there an appropriate umbrella term?
An environment of increasing risks, complex regulations and continuing cost pressures is impeding healthcare executives from moving quickly to seize untapped industry opportunities, according to the 7th annual UPS "Pain in the (Supply) Chain" survey. Globally, healthcare executives are planning for strategic partnerships and technology investment to mitigate risks and capitalize on growth opportunities.
Healthcare providers are adopting a networked approach, both for procurement and distribution of supplies. Robert Colosino, vice president of business development with Tecsys, outlines the advantages and implications of that strategy.
BravoSolution has entered into a partnership with SharedClarity to negotiate and manage contracts for the acquisition of medical devices by healthcare systems.